|Bid||0.0400 x 0|
|Ask||0.0450 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Construction of the planned 200,000 square foot greenhouse project is set to begin immediately. As with the Dorval facility, at Hemmingford, we will be growing the kind of high quality product that consumers are demanding. Matica is a multi-faceted, innovative company in the Quebec cannabis space.
TORONTO, ON / ACCESSWIRE / November 6, 2019 / Matica Enterprises Inc. (MMJ.CN) (MMJFF) (39N.F) ("Matica" or the "Company") is pleased to announce that RoyalMax Biotechnology Canada Inc. ("RoyalMax") has submitted to Health Canada applications for amendments to the current license to add a Standard Processing License and a Sales for Medical Purposes License. Upon receipt of these licences RoyalMax will begin sales of cannabis produced at its facility in Dorval, Quebec. Mr. Charn Deol, Matica CFO states that, "It will be exciting to show sales and revenue coming from Dorval.
TORONTO, ON / ACCESSWIRE / October 16, 2019 / Matica Enterprises Inc. (MMJ.CN) (MMJFF) (39N.F) ("Matica" or the "Company") announces that Mr. George A. Brown has taken early retirement for personal and health reasons and has resigned as Director and Chief Financial Officer effective October 15, 2019. Mr. Brown joined Matica in 2015 and has been one of the driving forces in the success of the Company. Mr. Gurcharn Deol, Director of Matica will act as interim CFO until a suitable replacement can be found.